Main navigation Conv. bonds Shareholders Corporate governance Analyst coverage Events Reports & webcasts Press releases Service Biocartis.com About us Downloads FAQ IR email alerts IR contact NL EN Highlight Open/Close Search Contact us +32 15 631 729 Social LinkedIn Facebook Youtube Twitter INVESTORS BIOCARTIS Press releases Financial calendar & events Financial reports & webcasts Corporate presentation SHAREHOLDERS Biocartis has an international shareholder structure with both large and smaller specialized shareholders in healthcare and life sciences, and a broad base of more local retail investors. See shareholders ACTUAL STOCK PRICE Biocartis is a commercial-stage, mid-cap molecular diagnostics (MDx) company listed on Euronext (ticker: BCART) since April 2015. CORPORATE GOVERNANCE Biocartis is an international company with a Belgian parent entity to which the Belgian Code on Corporate Governance applies. In accordance with the Corporate Governance Code, Biocartis has adopted a corporate governance charter, which describes the main aspects of Biocartis’ corporate governance, including its governance structure, the terms of reference of the board of directors and its committees and other important governance topics. Learn more Meet the team Download center FAQ IR email alerts Publications Certain statements, beliefs and opinions on this website are forward-looking, which reflect the Company's or, as appropriate, the Company directors’ or managements’ current expectations and projections concerning future events such as the Company's results of operations, financial condition, liquidity, performance, prospects, growth, strategies and the industry in which the Company operates. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward-looking statements contained on this website regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained on this website, those results or developments may not be indicative of results or developments in future periods. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements on this website as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained on this website or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date in the documents on this website. USEFUL LINKS Biocartis.com Euronext Biocartis Press releases IR CONTACT Biocartis NV Renate Degrave Head of IR & Corporate Communications Generaal de Wittelaan 11B 2800 Mechelen, Belgium Phone: +32 15 631 729 ir@biocartis.com DOWNLOAD CENTER PUBLICATIONS CORPORATE PRESENTATION LISTED ON EURONEXT Social LinkedIn Facebook Youtube Twitter Footer Cookie policy Privacy policy Terms of use © 2021 Investors Biocartis Created by O2 Agency